contentSlug

type

ContentSlug_ContentQuery

slug

ContentPageContentQuery

content

trendingContent

query ContentSlug_ContentQuery(
  $contentSlug: String!
  $type: [ContentType!]
) {
  ...ContentPageContentQuery_13QmVO
}

fragment CompanyDetails_Content on Content {
  __isContent: __typename
  companies {
    name
    description
    pageUrl
    id
  }
}

fragment ContentBasicInfo on Content {
  __isContent: __typename
  id
  type
  title
  lang
  companies {
    viewerIsFollowing
    id
    name
    pageUrl
  }
  tags {
    viewerIsFollowing
    id
    name
    pageUrl
  }
  ...PublishingDetails
  ...Reactions
}

fragment ContentMetadata on Content {
  __isContent: __typename
  type
  title
  lang
  pageUrl
  alternatePageUrls: translations {
    __typename
    pageUrl
    lang
  }
  imgUrl
  description
  ... on Video {
    liveTime
    videoUrl
  }
  ... on Webcast {
    liveTime
    videoUrl
  }
}

fragment ContentPageContentQuery_13QmVO on Query {
  content(slug: $contentSlug, type: $type) {
    __typename
    id
    type
    title
    isPremium
    lang
    htmlBody
    summary
    companies {
      forum {
        latestPosts {
          ...ForumPosts
        }
      }
      name
      id
      viewerIsFollowing
      pageUrl
      defaultInstrument {
        isin
        id
        marketOpen
        marketClose
        marketplace {
          region
        }
        returns {
          total
        }
      }
    }
    tags {
      viewerIsFollowing
      id
      name
      pageUrl
    }
    createdAt
    ... on Video {
      liveTime
    }
    ... on Webcast {
      liveTime
    }
    slug
    ... on CompanyReport {
      reportUrl
    }
    ... on ThirdPartyCompanyReport {
      reportUrl
    }
    ... on StockExchangeRelease {
      reportUrl
    }
    ...ContentBasicInfo
    ...ContentMetadata
    ...PriceAndRecommendation_Content
    ...CompanyDetails_Content
    ...ReportLink_Content
    ...KeyFigures_Content
  }
  ...TrendingContent_1jQ2Cn
}

fragment ForumPosts on ForumPost {
  text
  likesCount
  url
  author
  postedAt
  authorImgUrl
}

fragment KeyFigures_Content on Content {
  __isContent: __typename
  companies {
    defaultInstrument {
      estimateData {
        modelType
        reportingCurrency
      }
      snapshot {
        transaction {
          date
          actualized {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
          estimates {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
        }
      }
      id
    }
    id
  }
}

fragment PriceAndRecommendation_Content on Content {
  __isContent: __typename
  createdAt
  companies {
    name
    pageUrl
    defaultInstrument {
      priceData {
        tradeCurrency
      }
      snapshot {
        priceData {
          date
          lastPrice
          tradeCurrency
        }
        transaction {
          date
          recommendation
          targetPrice
        }
        prevTransaction {
          recommendation
        }
      }
      id
    }
    id
  }
}

fragment PublishingDetails on Content {
  __isContent: __typename
  createdAt
  publishers {
    name
    imgUrl
  }
  authors {
    __typename
    id
    name
    slug
    imgUrl
    jobTitle
  }
  ... on Video {
    liveTime
  }
  ... on Webcast {
    liveTime
  }
}

fragment Reactions on Content {
  __isContent: __typename
  id
  reactionGroups {
    reactionType
    reactionsCount
    viewerReacted
  }
}

fragment ReportLink_Content on Content {
  __isContent: __typename
  type
  isPremium
  ... on CompanyReport {
    reportUrl
  }
  ... on ThirdPartyCompanyReport {
    reportUrl
  }
  ... on StockExchangeRelease {
    reportUrl
  }
}

fragment TrendingContent_1jQ2Cn on Query {
  trendingContent(type: ARTICLE) {
    __typename
    id
    title
    lang
    pageUrl
    createdAt
    type
    imgUrl
    companies {
      squareLogoUrl
      name
      id
    }
    authors {
      __typename
      imgUrl
      id
    }
    publishers {
      imgUrl
    }
  }
}


rls-global-ab-rls-global-ab-publ-year-end-report-2020

__typename

title

isPremium

lang

htmlBody

summary

companies

createdAt

publishers

authors

reactionGroups

pageUrl

translations

imgUrl

description

OCTOBER 1[st]-DECEMBER 31[st]Net sales amounted to KSEK 139 (KSEK 54)Earnings before interest and taxes (EBIT) amounted to MSEK -7,2 (MSEK -8,9)Earning per share before dilution at SEK -0,11...

<hl2>OCTOBER 1[st]-DECEMBER 31[st]</hl2><ul><li>Net sales amounted to KSEK 139 (KSEK 54)</li><li>Earnings before interest and taxes (EBIT) amounted to MSEK -7,2 (MSEK -8,9)</li><li>Earning per share before dilution at SEK -0,11 (SEK -0,15)</li><li>Cash flow from operating activities amounted to MSEK -7,0 (MSEK -5,7)</li><li>Liquid assets at the end of the period MSEK 18,9 (MSEK 41,7)</li><li>Equity ratio was 88 % (90 %)</li></ul> <hl2>JANUARY 1[st]-DECEMBER 31[st]</hl2><ul><li>Net sales amounted to KSEK 2,043 (KSEK 1,023)</li><li>Earnings before interest and taxes (EBIT) amounted to MSEK -22,3 (MSEK -26,7)</li><li>Earning per share before dilution at SEK -0,34 (SEK-0,44)</li><li>Cash flow from operating activities amounted to MSEK -22,2 (MSEK-24,9)</li><li>Liquid assets at the end of the period MSEK 18,9 (MSEK 41,7)</li><li>Equity ratio was 88 % (90 %)</li></ul> <hl2>SUMMARY OF EVENTS DURING FOURTH QUARTER</hl2><ul><li>Continued focus on future regional/global cooperation.</li><li>RLS participated in EWMA, the European Wound Conference which this year was digital. Docent Jan Apelqvist presented an abstract from the ChloraSolv01 study.</li><li>A pre-study regarding automatic production has been conducted during fall.</li><li>New exciting results from tests performed in Lund.</li></ul> SUMMARY OF EVENTS DURING THE YEAR<hl2>SUMMARY OF EVENTS DURING Q1</hl2><ul><li>Redeye was appointed new Certified Adviser.</li><li>The immaterial rights regarding PeriSolv was sold to Regident AG.</li><li>RLS signed a contract with Region Kalmar län.</li></ul> <hl2>SUMMARY OF EVENTS DURING Q2</hl2><ul><li>RLS signed contracts with Region Stockholm/Gotland.</li><li>Increased use of ChloraSolv in Region Kalmar län.</li></ul> <hl2>SUMMARY OF EVENTS DURING Q3</hl2><ul><li>ChloraSolv approved in Canada.</li><li>RLS signed contract with Region Skåne.</li><li>Recurrent sales of ChloraSolv.</li></ul> <hl2>SUMMARY OF EVENTS AFTER FOURTH QUARTER</hl2><ul><li>RLS Global was audited by Eurofins and Lloyds (notified bodies) with very good result.</li></ul> <hl2>COVID-19</hl2><ul><li>In the current situation, the Board has considered the impact of different possible future covid-19 related scenarios.</li><li>Since the healthcare sector is so extremely strained under the prevailing circumstances, all processes take longer which affects our market penetration and other activities, resulting in RLS focusing even more on R&amp;D projects.</li></ul> TRADING PLACE AND CERTIFIED ADVISER RLS Global's shares have been listed on the Nasdaq First North Growth Market since 17[th] May, 2017 and trading takes place under the short name RLS. Certified Adviser is Redeye Aktiebolag. phone: +46 8 121 576 90, email: <virtloc>certifiedadviser@redeye.se.</virtloc> During the period 2012-2017, the company was listed on Aktietorget.The Year-end report is enclosed and is also available at: <a href="https://rls.global/wp-content/uploads/2021/02/RLS_Global_Q4_2020_EN.pdf">https://rls.global/wp-content/uploads/2021/02/RLS_Global_Q4_2020_EN.pdf</a>PUBLICATION This information was submitted for publication through the agency of the above contact person, at 09.00 CET on February 10th, 2021.